Karen J. Chave

430 total citations
20 papers, 353 citations indexed

About

Karen J. Chave is a scholar working on Molecular Biology, Biochemistry and Materials Chemistry. According to data from OpenAlex, Karen J. Chave has authored 20 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Biochemistry and 6 papers in Materials Chemistry. Recurrent topics in Karen J. Chave's work include Amino Acid Enzymes and Metabolism (10 papers), Enzyme Structure and Function (6 papers) and Cancer Research and Treatments (5 papers). Karen J. Chave is often cited by papers focused on Amino Acid Enzymes and Metabolism (10 papers), Enzyme Structure and Function (6 papers) and Cancer Research and Treatments (5 papers). Karen J. Chave collaborates with scholars based in United States, United Kingdom and Finland. Karen J. Chave's co-authors include John Galivan, Thomas J. Ryan, Myung S. Rhee, Thomas J. Ryan, Rong Yao, Dezhong Yin, Barbara Lindau‐Shepard, Patrick Van Roey, Hongmin Li and T.J. RYAN and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Pharmacology & Therapeutics.

In The Last Decade

Karen J. Chave

20 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen J. Chave United States 11 184 140 107 86 47 20 353
Stephanie Wickham United States 11 164 0.9× 30 0.2× 42 0.4× 136 1.6× 36 0.8× 13 404
Marc N. Offman United Kingdom 7 190 1.0× 21 0.1× 133 1.2× 9 0.1× 21 0.4× 8 298
Philips Fs 4 94 0.5× 21 0.1× 137 1.3× 15 0.2× 11 0.2× 10 251
Alessio Fiascarelli Italy 7 246 1.3× 49 0.3× 7 0.1× 51 0.6× 57 1.2× 13 328
Natalie Schneiderman United States 5 289 1.6× 30 0.2× 25 0.2× 17 0.2× 4 0.1× 6 370
Waikin Chan United States 7 291 1.6× 23 0.2× 52 0.5× 6 0.1× 13 0.3× 10 384
Jørgen Lyngbye Denmark 13 238 1.3× 293 2.1× 16 0.1× 3 0.0× 33 0.7× 26 529
W P Gati Canada 14 152 0.8× 10 0.1× 47 0.4× 57 0.7× 6 0.1× 19 398
Alan Fotoohi Sweden 12 110 0.6× 20 0.1× 140 1.3× 7 0.1× 9 0.2× 17 366
Joseph A. Combs United States 5 164 0.9× 20 0.1× 10 0.1× 73 0.8× 20 0.4× 7 311

Countries citing papers authored by Karen J. Chave

Since Specialization
Citations

This map shows the geographic impact of Karen J. Chave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen J. Chave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen J. Chave more than expected).

Fields of papers citing papers by Karen J. Chave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen J. Chave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen J. Chave. The network helps show where Karen J. Chave may publish in the future.

Co-authorship network of co-authors of Karen J. Chave

This figure shows the co-authorship network connecting the top 25 collaborators of Karen J. Chave. A scholar is included among the top collaborators of Karen J. Chave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen J. Chave. Karen J. Chave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yates, Jennifer L., Danielle Hunt, Karen E. Kulas, et al.. (2023). Development of a novel serological assay for the detection of mpox infection in vaccinated populations. Journal of Medical Virology. 95(10). e29134–e29134. 10 indexed citations
2.
Eisele, Leslie E., et al.. (2006). Characterization of Human γ-glutamyl hydrolase in solution demonstrates that the enzyme is a non-dissociating homodimer. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764(9). 1479–1486. 5 indexed citations
4.
Volk, Erin L., et al.. (2003). A rapid assay for the quantitation of γ-glutamyl hydrolase using a fluorogenic peptide as substrate. BioTechniques. 35(5). 926–932. 3 indexed citations
5.
Li, Hongmin, Thomas J. Ryan, Karen J. Chave, & Patrick Van Roey. (2002). Three-dimensional Structure of Human γ-Glutamyl Hydrolase. Journal of Biological Chemistry. 277(27). 24522–24529. 27 indexed citations
6.
Snell, Keith, et al.. (2000). The genetic organization and protein crystallographic structure of human serine hydroxymethyltransferase. Advances in Enzyme Regulation. 40(1). 353–403. 11 indexed citations
7.
Galivan, John, Thomas J. Ryan, Karen J. Chave, et al.. (2000). Glutamyl hydrolasepharmacological role and enzymatic characterization. Pharmacology & Therapeutics. 85(3). 207–215. 69 indexed citations
8.
Chave, Karen J., Ivan E. Auger, John Galivan, & Thomas J. Ryan. (2000). Molecular Modeling and Site-directed Mutagenesis Define the Catalytic Motif in Human γ-Glutamyl Hydrolase. Journal of Biological Chemistry. 275(51). 40365–40370. 21 indexed citations
9.
Chave, Karen J., John Galivan, & Thomas J. Ryan. (1999). Site-directed mutagenesis establishes cysteine-110 as essential for enzyme activity in human γ-glutamyl hydrolase. Biochemical Journal. 343(3). 551–555. 9 indexed citations
10.
Galivan, John, T.J. RYAN, Myung S. Rhee, Rong Yao, & Karen J. Chave. (1999). Glutamyl hydrolase: properties and pharmacologic impact.. PubMed. 26(2 Suppl 6). 33–7. 17 indexed citations
11.
Chave, Karen J., John Galivan, & Thomas J. Ryan. (1999). Site-directed mutagenesis establishes cysteine-110 as essential for enzyme activity in human γ-glutamyl hydrolase. Biochemical Journal. 343(3). 551–551. 6 indexed citations
12.
Chave, Karen J., John Galivan, & Thomas J. Ryan. (1999). Site-directed mutagenesis establishes cysteine-110 as essential for enzyme activity in human gamma-glutamyl hydrolase.. PubMed. 343 Pt 3. 551–5. 16 indexed citations
13.
Yin, Dezhong, et al.. (1999). Structural organization of the human γ-glutamyl hydrolase gene. Gene. 238(2). 463–470. 12 indexed citations
14.
Renwick, Suzanne, et al.. (1998). Purification, crystallization and preliminary X-ray analysis of human recombinant cytosolic serine hydroxymethyltransferase. Acta Crystallographica Section D Biological Crystallography. 54(5). 1030–1031. 14 indexed citations
15.
Rhee, Myung S., Barbara Lindau‐Shepard, Karen J. Chave, John Galivan, & Thomas J. Ryan. (1998). Characterization of human cellular gamma-glutamyl hydrolase.. PubMed. 53(6). 1040–6. 42 indexed citations
16.
Rhee, Myung S., Barbara Lindau‐Shepard, Karen J. Chave, John Galivan, & T.J. RYAN. (1998). Characterization of Human Cellular γ-Glutamyl Hydrolase. Molecular Pharmacology. 53(6). 1040–1046. 14 indexed citations
17.
Chave, Karen J., Keith Snell, & Peter Sanders. (1997). Isolation and characterisation of human genomic sequences encoding cytosolic serine hydroxymethyltransferase. Biochemical Society Transactions. 25(1). 53S–53S. 3 indexed citations
18.
Byrne, P., Janet Shipley, Karen J. Chave, Peter Sanders, & Keith Snell. (1996). Characterisation of a human serine hydroxymethyltransferase pseudogene and its localisation to 1p32.3–33. Human Genetics. 97(3). 340–344. 10 indexed citations
19.
Chave, Karen J., Suzanne Renwick, Peter Sanders, & Keith Snell. (1995). Site directed mutagenesisof human cytosolic serine hydroxymethyltransferase. Biochemical Society Transactions. 23(4). 622S–622S. 1 indexed citations
20.
Renwick, Suzanne, et al.. (1995). Overexpression of human cytosolic serine hydroxymethyl-transferase in E. coli. Biochemical Society Transactions. 23(4). 624S–624S. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026